Studies on the interaction mechanism of aminopyrene derivatives with human tumor-related DNA

Li Li1, Jia Lu, Wenshu Zhou

  • 1Jiangsu Key Laboratory of New Power Batteries, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210097, China.

Insights

This study investigated how amino-polycyclic aromatic hydrocarbons (PAHs) interact with human tumor DNA. Results show varying binding affinities and mechanisms, potentially altering DNA structure.

Area of Science:

  • Environmental Chemistry
  • Molecular Biology
  • Toxicology

Background:

  • Polycyclic aromatic hydrocarbons (PAHs) derivatives are known carcinogens.
  • Amino-PAHs pose risks for human malignant diseases.
  • Understanding their DNA interaction is crucial for risk assessment.

Purpose of the Study:

  • To evaluate the interactions between specific amino-PAHs and human tumor-related DNA.
  • To elucidate the binding mechanisms and affinities of these compounds.
  • To investigate the structural consequences of amino-PAH binding to DNA.

Main Methods:

  • Spectroscopic techniques were employed to analyze PAH-DNA interactions.
  • Polyacrylamide gel electrophoresis (PAGE) was used to assess DNA conformational changes.
  • Binding constants were determined for the amino-PAH-DNA complexes.

Main Results:

  • Significant interactions were observed between amino-PAHs and targeted DNA.
  • 1-Aminopyrene (1-AP) exhibited stronger binding (10^6 L/mol) than 1-pyrenebutanoic acid (1-PBA) (10^3 L/mol).
  • 1-AP primarily intercalated via electrostatic forces; 1-PBA intercalated with Van der Waals forces and hydrogen bonds.
  • Amino-PAH binding was stronger to p53 DNA than C-myc DNA.
  • Amino-PAH binding induced DNA conformational changes from duplex to antiparallel G-quadruplex.

Conclusions:

  • Amino-PAHs interact with human tumor DNA through distinct mechanisms.
  • Binding affinity and mode depend on the PAH's chemical structure.
  • These interactions can alter DNA conformation, potentially impacting gene function and disease pathways.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.